Charles River has entered into a partnership with Wheeler Bio to expedite the pr...
The FDA has accepted Regeneron’s biologics licence application (BLA) for linvose...
One common factor can help make supply chains more comprehensible, resilient and...
The company will evaluate an IMC-F106C/Opdivo combination treatment in a Phase I...
Harmony is advancing pitolisant into a Phase III clinical trial that is expected...
The company’s monoclonal antibody therapy, IO-202, has received its second orpha...
United has commenced litigation with the FDA to combat Liquidia’s Yutrepia encro...
Large hospitals are experimenting with generative AI at a time when there are no...
Ring Therapeutics, a gene therapy startup launched by Flagship Pioneering, has l...
Drug makers are doing everything to tap the bottomless well of demand for new ob...
Seniors are still flocking to Medicare Advantage even if some insurers fell shor...
An increasing number of medical device companies are submitting fabricated and u...
AbbVie CEO Richard Gonzalez has been a subject of nearly constant criticism, but...
German pharmaceutical giant Bayer is slashing its dividend by 95%, part of an on...
China has more obese people than anywhere else in the world, and they are increa...
A U.S. appeals court revived a controversial lawsuit that alleged people were ha...